keyword
MENU ▼
Read by QxMD icon Read
search

prednisone long term effects

keyword
https://www.readbyqxmd.com/read/30301458/syringomyelia-like-syndrome-in-neuromyelitis-optica-spectrum-disorder-complicated-with-sjogren-s-syndrome-a-case-report
#1
Xiangling Li, Zhengqi Lu, Yanqiang Wang
BACKGROUND: Besides CSF-flow obstruction, syringomyelia is associated with inflammatory spinal cord lesions. However, syringomyelia-like syndrome concomitant with neuromyelitis optica spectrum disorder (NMOSD) and primary Sjogren's syndrome (pSS) is extremely rare. Here, we would like to report a case of a patient with syringomyelia-like syndrome in NMOSD complicated with Sjogren's Syndrome. CASE PRESENTATION: A 64-old male Han Chinese, presented with three episodes of acute demyelinating processes in the central nervous system within 5 years...
October 9, 2018: BMC Neurology
https://www.readbyqxmd.com/read/30242442/diagnosis-and-clinical-course-of-three-adolescents-with-amiodarone-induced-hyperthyroidism
#2
Julia Gesing, Julia Hoppmann, Roman Gebauer, Roland Pfäffle, Astrid Bertsche, Wieland Kiess
Amiodarone-induced hyperthyroidism is a known side effect of amiodarone treatment. In the pediatric population, long-term amiodarone treatment is rarely indicated because of its severe side effects including thyroid function impairment. Treatment is therefore restricted to therapy-resistant arrhythmias. In the literature, scarce data are available on the management and therapy of amiodarone-induced thyroid dysfunction at a young age. We present three adolescent patients developing amiodarone-induced thyrotoxicosis in the months after amiodarone therapy...
September 21, 2018: Pediatric Cardiology
https://www.readbyqxmd.com/read/30197508/glucocorticoid-induced-delayed-fracture-healing-and-impaired-bone-biomechanical-properties-in-mice
#3
Yan-Zhi Liu, Mohammed P Akhter, Xiang Gao, Xiao-Yan Wang, Xiao-Bei Wang, Gang Zhao, Xin Wei, Hao-Jun Wu, Hang Chen, Dong Wang, Liao Cui
Background: The objective of the study was to investigate the effects of glucocorticoid (GC) on the fracture healing process in a closed femur fracture mice model. Materials and methods: Forty 12-week-old female CD-1 mice were randomly allocated into four groups: healthy control and mice with prednisone exposure (oral gavage), 6 mg/kg/day (GC-L), 9 mg/kg/day (GC-M) and 12 mg/kg/day (GC-H). Three weeks after the initiation of prednisone dosing, closed femur fractures were created on prednisone-exposed mice and the healthy control...
2018: Clinical Interventions in Aging
https://www.readbyqxmd.com/read/30159547/alzheimer-s-disease-and-intranasal-fluticasone-propionate-in-the-fda-medwatch-adverse-events-database
#4
Steven Lehrer, Peter H Rheinstein
Background: Studies of Alzheimer's disease suggest that neuroinflammation or deranged brain wound healing may be a cause of some cases. But a placebo controlled study showed no effect at all on Alzheimer's disease of low dose oral prednisone after one year. Introducing the steroid directly into the hippocampus and rhinencephalon via the nose, as happens in hay fever subjects, could be more effective. Objective: In the present study, we analyzed FDA MedWatch data for intranasal fluticasone propionate (Flonase) to determine the frequency of Alzheimer's disease as an adverse event reported after use of the medication...
2018: JAD reports
https://www.readbyqxmd.com/read/30142801/bilateral-thalamic-and-mesencephalic-infarctions-with-hypopituitarism-as-long-term-complications-postradiotherapy-a-case-report
#5
Liang Hui, Hu Shijun, Liu Tao, Wen Guoqiang, Huang Shixiong
BACKGROUND: Radiation is widely used as the first-line treatment for nasopharyngeal carcinoma (NPC) and improves survival. Nevertheless, radiation also places the patients at risk of radiation-induced adverse effects, such as transient ischemic attack, ischemic stroke, hypopituitarism, and cranial nerve and temporal lobe dysfunction. CASE REPORT: A 54-year-old woman who had undergone radiation treatment for NPC 14 years earlier and had no cerebrovascular risk factors, visited our department 4 days after sudden onset of consciousness disturbance...
August 2018: Medicine (Baltimore)
https://www.readbyqxmd.com/read/30135417/early-sirolimus-based-immunosuppression-is-safe-for-lung-transplantation-patients-retrospective-single-arm-exploratory-study
#6
Jacek Wojarski, Sławomir Żegleń, Marek Ochman, Wojtek Karolak
BACKGROUND Sirolimus, a mechanistic target of sirolimus inhibitor, is an immunosuppression medication for patients undergoing heart and abdominal transplantation. Sirolimus-based immunosuppression administered de novo post-lung transplantation is associated with bronchial anastomosis healing-related complications. We hypothesized that sirolimus administration within the first postoperative month in selected lung transplant recipients is safe and may be associated with favorable short-term and long-term outcomes due to its anti-proliferative properties and minimal adverse side effects...
August 23, 2018: Annals of Transplantation: Quarterly of the Polish Transplantation Society
https://www.readbyqxmd.com/read/30099821/switch-from-abiraterone-plus-prednisone-to-abiraterone-plus-dexamethasone-at-asymptomatic-psa-progression-in-patients-with-metastatic-castration-resistant-prostate-cancer
#7
Charlotte Fenioux, Christophe Louvet, Emilie Charton, Francois Rozet, Stanislas Ropert, Dominique Prapotnich, Eric Barret, Rafael Sanchez-Salas, Annick Mombet, Nathalie Cathala, Marie-Liesse Joulia, Jean-Luc Molitor, Julie Henriques, Franck Bonnetain, Xavier Cathelineau, Mostefa Bennamoun
OBJECTIVE: To evaluate the effects of switching from prednisone (P) to dexamethasone (D) at asymptomatic prostate-specific antigen (PSA) progression in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA). MATERIALS AND METHODS: Among 93 patients treated with AA between January 2013 and April 2016 in our institution, 48 consecutive asymptomatic patients with mCRPC, who experienced biochemical progression on treatment with AA+P 10 mg/day, were included...
August 11, 2018: BJU International
https://www.readbyqxmd.com/read/30020020/medical-adherence-in-patients-with-systemic-lupus-erythematosus-in-germany-predictors-and-reasons-for-non-adherence-a-cross-sectional-analysis-of-the-lula-cohort
#8
G Chehab, G M Sauer, J G Richter, R Brinks, R Willers, R Fischer-Betz, B Winkler-Rohlfing, M Schneider
Objective Adherence to medication has a major impact on treatment control and success especially in chronic diseases but often remains unrecognized. Besides clinical, socioeconomic, disease-related and treatment-related parameters, general and personal health beliefs, as well as perception of health, can affect adherence. Our aim was to investigate the adherence to lupus-specific medications in German lupus patients and to assess influencing factors including detrimental or beneficial effects of health perceptions and beliefs...
September 2018: Lupus
https://www.readbyqxmd.com/read/30002799/successful-management-of-kaposiform-hemangioendothelioma-with-long-term-sirolimus-treatment-a-case-report-and-review-of-the-literature
#9
Matteo Chinello, Daniela Di Carlo, Francesca Olivieri, Rita Balter, Massimiliano De Bortoli, Virginia Vitale, Ada Zaccaron, Elisa Bonetti, Alice Parisi, Simone Cesaro
Background: Kaposiform Hemangioendothelioma (KHE) is a rare vascular tumour of the infancy and the first decade of life. It is locally aggressive and potentially life threatening when associated with consumptive coagulopathy, known as Kasabach-Merritt syndrome (KMS). No consensus or guideline for the therapy has been reached because of the lack of prospective trials, and the different standard care suggestions are based on retrospective case series. Case report: We report the case of a 9-month-old male with KHE and KMS in which the initial response, obtained with prednisone and vincristine, was subsequently consolidated and strengthened by long-term treatment with sirolimus, a mTOR inhibitor...
2018: Mediterranean Journal of Hematology and Infectious Diseases
https://www.readbyqxmd.com/read/29998211/long-term-treatment-with-infliximab-in-pediatric-vogt-koyanagi-harada-disease
#10
Gustavo A Budmann, Ludmila García Franco, Alejandra Pringe
Purpose: To report a case of pediatric Vogt-Koyanagi-Harada (VKH) successfully treated with infliximab and methotrexate for ten years. Observations: A 9-year-old Hispanic girl with VKH disease, was successfully treated with oral methotrexate 15 mg/week and oral prednisone 40 mg/day (1mg/kg/day). But when oral prednisone was tapered to 10 mg/day over a 3-month period, inflammation recurred. Patient was considered as corticosteroid-dependent thus infliximab 7mg/kg/pulse was started on days 0, 15, 60 and every 60 days thereafter...
September 2018: American Journal of Ophthalmology Case Reports
https://www.readbyqxmd.com/read/29978586/retrospective-analysis-of-the-usefulness-of-a-protocol-with-high-dose-methotrexate-in-polymyalgia-rheumatica-results-of-a-single-center-cohort-of-100-patients
#11
Luca Quartuccio, Giorgia Gregoraci, Miriam Isola, Salvatore De Vita
AIM: The aim of the present study was to define subsets of patients suffering from polymyalgia rheumatica, where methotrexate (MTX) up to 20 mg/week might be more effective. METHODS: A total of 100 patients with polymyalgia rheumatica treated with MTX were studied. The criteria for MTX introduction were: (i) relapse during the first month of therapy, when tapering glucocorticoids (GC); (ii) requiring long-term GC (i.e. >24 consecutive months); (iii) requiring ≥5 mg/day of prednisone equivalents after 4 months of GC therapy; (iv) GC-related side-effects; and (v) a high risk of GC-related side-effects...
September 2018: Geriatrics & Gerontology International
https://www.readbyqxmd.com/read/29954931/a-phase-ii-iii-randomized-multicenter-trial-of-prednisone-sirolimus-vs-prednisone-sirolimus-calcineurin-inhibitor-for-treatment-of-chronic-graft-versus-host-disease-bmt-ctn-0801
#12
Paul A Carpenter, Brent R Logan, Stephanie J Lee, Daniel J Weisdorf, Laura Johnston, Luciano J Costa, Carrie L Kitko, Javier Bolaños-Meade, Stefanie Sarantopoulos, Amin M Alousi, Sunil Abhyankar, Edmund K Waller, Adam Mendizabal, Jiaxi Zhu, Kelly A O'Brien, Aleksandr Lazaryan, Juan Wu, Eneida R Nemecek, Steven Z Pavletic, Corey S Cutler, Mary M Horowitz, Mukta Arora
Initial therapy of chronic graft-versus-host disease is prednisone ± calcineurin-inhibitor, but most patients respond inadequately. In a randomized, adaptive phase 2/3 multicenter trial we studied whether prednisone/sirolimus or prednisone/sirolimus/photopheresis was more effective than prednisone/sirolimus/calcineurin-inhibitor for treating chronic graft-versus-host disease in treatment-naive or early inadequate responders. Primary endpoints were proportions of subjects alive without relapse or secondary therapy with 6-month complete or partial response in phase-2, or with 2-year complete response in phase-3...
June 28, 2018: Haematologica
https://www.readbyqxmd.com/read/29932254/long-term-immunosuppression-for-cns-mouse-xenotransplantation-effects-on-nigrostriatal-neurodegeneration-and-neuroprotective-carotid-body-cell-therapy
#13
Javier Villadiego, Sonia Romo-Madero, Roberto García-Swinburn, Nela Suárez-Luna, Alfonso Bermejo-Navas, Miriam Echevarría, Juan J Toledo-Aral
BACKGROUND: The use of long-term immunosuppressive treatments on neural transplantation has been controversial during the last decades. Although nowadays there is a consensus about the necessity of maintaining a permanent state of immunosuppression to preserve the survival of cerebral grafts, little is known about the effects that chronic immunosuppression produces both on the neurodegenerative process and on transplants function. METHODS: Here, we establish a new immunosuppressive protocol, based on the discontinuous administration of CsA (15 mg/kg; s...
June 22, 2018: Xenotransplantation
https://www.readbyqxmd.com/read/29925692/double-stranded-rna-innate-immune-response-activation-from-long-term-adeno-associated-virus-vector-transduction
#14
Wenwei Shao, Lauriel F Earley, Zheng Chai, Xiaojing Chen, Junjiang Sun, Ting He, Meng Deng, Matthew L Hirsch, Jenny Ting, R Jude Samulski, Chengwen Li
Data from clinical trials for hemophilia B using adeno-associated virus (AAV) vectors have demonstrated decreased transgenic coagulation factor IX (hFIX) expression 6-10 weeks after administration of a high vector dose. While it is likely that capsid-specific cytotoxic T lymphocytes eliminate vector-transduced hepatocytes, thereby resulting in decreased hFIX, this observation is not intuitively consistent with restored hFIX levels following prednisone application. Although the innate immune response is immediately activated following AAV vector infection via TLR pathways, no studies exist regarding the role of the innate immune response at later time points after AAV vector transduction...
June 21, 2018: JCI Insight
https://www.readbyqxmd.com/read/29883261/muscle-mirnaome-shows-suppression-of-chronic-inflammatory-mirnas-with-both-prednisone-and-vamorolone
#15
Alyson A Fiorillo, Christopher B Tully, Jesse M Damsker, Kanneboyina Nagaraju, Eric P Hoffman, Christopher R Heier
Corticosteroids are highly prescribed and effective anti-inflammatory drugs but the burden of side effects with chronic use significantly detracts from patient quality of life, particularly in children. Developing safer steroids amenable to long-term use is an important goal for treatment of chronic inflammatory diseases such as Duchenne muscular dystrophy (DMD). We have developed vamorolone (VBP15), a first-in-class dissociative glucocorticoid receptor (GR) ligand that shows the anti-inflammatory efficacy of corticosteroids without key steroid side effects in animal models...
September 1, 2018: Physiological Genomics
https://www.readbyqxmd.com/read/29843820/successful-treatment-of-primary-bone-marrow-hodgkin-lymphoma-with-brentuximab-vedotin-a-case-report-and-review-of-the-literature
#16
Keiki Nagaharu, Masahiro Masuya, Yuki Kageyama, Takanori Yamaguchi, Ryugo Ito, Keiki Kawakami, Masafumi Ito, Naoyuki Katayama
BACKGROUND: Hodgkin lymphoma usually presents with sequential enlargement of peripheral lymph nodes, and bone marrow invasion rarely occurs (approximately 3-5%). However, several cases have been reported as "primary" bone marrow Hodgkin lymphoma, especially among patients with human immunodeficiency virus and the elderly. This type of Hodgkin lymphoma is characterized by no peripheral lymphadenopathies and has been reported to have poorer prognosis. CASE PRESENTATION: A 38-year-old Japanese man was admitted to our hospital because of fever of unknown origin and pancytopenia without lymphadenopathies...
May 30, 2018: Journal of Medical Case Reports
https://www.readbyqxmd.com/read/29787923/epileptic-spasms-evidence-for-oral-corticosteroids-and-implications-for-low-and-middle-income-countries
#17
REVIEW
Sharika V Raga, Jo M Wilmshurst
Implementation of international guidelines for the treatment of epileptic spasms, is challenging when access to adrenocorticotrophic hormone (ACTH) and vigabatrin is restricted, especially in Low and Middle Income Countries (LMIC). Oral corticosteroids are alternative interventions but evidence for the optimal agent, dose, duration, efficacy and long-term effects is lacking. A systematic review of the literature was performed to assess the quality of evidence of prednisone and prednisolone (oral corticosteroids) for the management of epileptic spasms...
July 2018: Seizure: the Journal of the British Epilepsy Association
https://www.readbyqxmd.com/read/29775447/-mycophenolate-mofetil-mmf-as-the-first-choice-immunosuppressive-drug-in-treatment-of-steroid-dependent-nephrotic-syndrome-in-children
#18
Iwona Ogarek, Elżbieta Szczęsny-Choruz, Ewa Wierzchowska-Słowiaczek, Joanna Kwinta-Rybicka, Zofia Stec, Anna Moczulska, Katarzyna Wilkosz, Dorota Drożdż
Most children diagnosed with nephrotic syndrome show favourable response to corticosteroid therapy, nonetheless 30% of patients have frequent relapses or a steroid-dependent course of disease. Cyclophosphamide, cyclosporin A or MMF are being used in treatment of steroid-dependent nephrotic syndrome in search of a drug with highest long-term effectiveness and least amount of side effects. AIM: The aim of study was to assess of the efficacy of MMF as the first choice immunosuppressive drug in children with nephrotic syndrome after determining a steroid-dependency...
April 23, 2018: Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego
https://www.readbyqxmd.com/read/29722038/long-term-abiraterone-withdrawal-syndrome
#19
S Marin, R Querol, L Campins, M Miarons, A Font, P Lianes
WHAT IS KNOWN AND OBJECTIVE: Abiraterone acetate (AA) is an androgen receptor axis inhibitor, indicated together with prednisone, for metastatic castration-resistant prostate cancer. Withdrawal syndrome for classical antiandrogen treatments is well known, but not so known for AA. Abiraterone withdrawal syndrome (AWS) could be related to simultaneous prednisone discontinuation or to an androgenic effect of AA metabolites. CASE DESCRIPTION: A case is described of a patient with long-term AWS without prednisone discontinuation...
October 2018: Journal of Clinical Pharmacy and Therapeutics
https://www.readbyqxmd.com/read/29603428/retrospective-analysis-of-frontline-treatment-efficacy-in-elderly-patients-with-diffuse-large-b-cell-lymphoma
#20
Chieh-Lung Cheng, Jia-Hau Liu, Sheng-Chieh Chou, Ming Yao, Jih-Luh Tang, Hwei-Fang Tien
OBJECTIVES: To investigate the effectiveness of 2 chemotherapeutic regimens, bendamustine plus rituximab (BR) or reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab (RD-R-CHOP), in elderly patients with treatment-naïve diffuse large B-cell lymphoma. METHODS: A retrospective study was conducted to investigate the efficacy and safety of 2 frontline regimens, BR and RD-R-CHOP, in patients aged ≥75 years unfit for R-CHOP. RESULTS: From January 2011 to December 2015, 26 patients received BR and 34 RD-R-CHOP...
July 2018: European Journal of Haematology
keyword
keyword
170864
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"